The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
JACKSONVILLE, Fla., June 17, 2025 /CNW/ -- Johnson & Johnson,§ a global leader in eye health, announced today that it is expanding its portfolio of presbyopia-correcting intraocular lenses (PC - IOL) ...
ClearSight is now offering the Tecnis Odyssey Lens, a next-generation intraocular lens (IOL) designed for patients undergoing cataract surgery or Custom Lens Replacement. This advanced lens technology ...
Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in ...
The new approvals are the latest in Johnson & Johnson’s IOLs; the Company claims the new TECNIS Eyhance IOL can slightly extend the depth of focus and deliver better image contrast. The Food and Drug ...
Johnson & Johnson Vision (JNJ) has received approval in the US for TECNIS Synergy and TECNIS Synergy Toric II IOLs. In Canada, it received approval for TECNIS Synergy Toric II IOLs. This ...
ABBOTT PARK, Ill., June 24, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Marking (Conformite Europeenne) in Europe for the TECNIS ® Symfony Extended Range of Vision ...
Abbott won FDA approval for the Tecnis Symfony intraocular lenses that are implanted during cataract surgeries. These are the first such lenses available in the U.S. that have a large range of focus ...
LAKE CHARLES, LA (KPLC) - Lens implants are used to treat patients with cataracts, but most lenses only focus on specific vision issues, like nearsightedness or farsightedness. In this Healthcast, we ...
New Delhi: Johnson & Johnson (J&J) has introduced the TECNIS PureSee, a purely refractive intraocular lens (IOL) designed for individuals with presbyopia, in India. The TECNIS PureSee IOL delivers ...
SANTA ANA, Calif., Feb. 2, 2021 /PRNewswire/ -- Johnson & Johnson Vision**, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies***, today announced that the U.S.